System and method for monitoring , reporting, managing and administering the treatment of a blood component
First Claim
1. A system for blood product treatment, the system comprising:
- a processor;
a memory being operably connected to the processor, the memory storing a blood product treatment module;
at least one blood product treatment instrument for communicating information related to blood product treatment to the processor and memory over a communications network for treating a blood product; and
, an interface having means for entering information, means for displaying information, and means for communicating with the processor and memory, the information being related to the blood product treatment, wherein the processor, the memory, and the interface are for at least one of monitoring, managing, reporting, and administering the blood product treatment.
6 Assignments
0 Petitions
Accused Products
Abstract
A system and method for treating a biological fluid unit wherein the system ensures proper execution of the treatment by coordinating cooperation among a plurality of components operably connected to the system. The system components include a processor communicating with a memory, a unit identifier, at least one blood component treatment process, and an illumination instrument. The system includes a database stored in and accessible from the memory. The database retains information associated with a blood component, an illumination instrument, and treatment of the blood component utilizing the illumination instrument. A user interface operably connected to the processor includes a graphical screen and a data entry device for communicating information related to the blood component treatment to and from the operator.
-
Citations
96 Claims
-
1. A system for blood product treatment, the system comprising:
-
a processor;
a memory being operably connected to the processor, the memory storing a blood product treatment module;
at least one blood product treatment instrument for communicating information related to blood product treatment to the processor and memory over a communications network for treating a blood product; and
,an interface having means for entering information, means for displaying information, and means for communicating with the processor and memory, the information being related to the blood product treatment, wherein the processor, the memory, and the interface are for at least one of monitoring, managing, reporting, and administering the blood product treatment. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 95, 96)
-
-
30. A method for at least one of monitoring, reporting, managing, and administering a blood product non-apheresis treatment, the method comprising the steps of:
-
providing for registering a blood product; and
,providing for storing blood product treatment information from a treatment instrument. - View Dependent Claims (31, 32, 33, 34, 35)
-
-
36. For a blood product treatment system, the system comprising a memory having a database and a blood product treatment module, a processor operably connected to at least one treatment instrument and to the memory, and an interface operably connected to the processor for facilitating a blood product treatment, a method for at least one of monitoring, reporting, managing, and administering a blood product treatment comprising the steps of:
-
providing for receiving a blood product identifier identifying a blood product; and
,providing for receiving a treatment kit identifier identifying a treatment kit. - View Dependent Claims (37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)
-
-
79. A computer readable medium having an application therein for at least one of monitoring, reporting, managing, and administering a blood product treatment of a blood product, the medium comprising:
-
a first segment for receiving blood product identification information; and
,a second segment for tracking the status of the blood product treatment of the blood product throughout the blood product treatment by reference to blood product treatment identification information. - View Dependent Claims (80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94)
-
Specification